Results 231 to 240 of about 4,795,723 (322)

Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning.

Journal of Clinical Oncology, 2014
C. Kanakry, P. O'Donnell, T. Furlong, M. de Lima, Wei Wei, M. Medeot, M. Mielcarek, R. Champlin, Richard J. Jones, P. Thall, B. Andersson, L. Luznik   +11 more
semanticscholar   +1 more source

Effectiveness of antiemetic regimens in controlling chemotherapy induced nausea and vomiting during hematopoietic stem cell transplantation. [PDF]

Sci Rep
Suárez-Casillas P, Ciudad-Gutiérrez P, Pérez-Moreno MA, Blázquez-Goñi C, Domínguez FMM, Pérez-Simón JA, Martín LA.   +6 more
europepmc   +1 more source

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia [PDF]

, 2019
et al,, Uy, Geoffrey, Yeshurun, Moshe
core   +1 more source

Targeting the Spleen as an Alternative Site for Hematopoiesis [PDF]

, 2019
Lim, Hong, O'Neill, Helen C, Short, Christie, Tan, Jonathan Kah Huat   +3 more
core   +1 more source

More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

, 2018
Jeremy J. Pappacena, Valkal Bhatt, Gunjan L. Shah, Patrick Hilden, Molly Maloy, Larry W. Buie, Sergio Giralt, Michael Scordo   +7 more
openalex   +1 more source

Non-T-Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP/EBMT. [PDF]

Am J Hematol
Nagler A, Kayser S, Ferhat AT, Kröger N, Eder M, Socié G, Blaise D, Schroeder T, Labussière-Wallet H, Maertens J, Busca A, Forcade E, Gedde-Dahl T, Rambaldi A, Bulabois CE, Bug G, Bazarbachi A, Brissot E, Savani B, Mohty M, Ciceri F.   +20 more
europepmc   +1 more source

High Donor and Recipient Age Are Not Risk Factors for Chronic Graft-Versus-Host Disease in the Setting of Anti-Thymocyte Globulin-Conditioned Hematopoietic Stem Cell Transplantation

, 2013
Andrew Lim, Jan Storek, Ashanka Beligaswatte, Marnie Collins, Kate Mason, Emily Peizhen Li, Ahsan Chaudhry, James A. Russell, Andrew Daly, Jeff Szer, Ian A. Lewis, David Ritchie   +11 more
openalex   +1 more source

Donor lymphocyte infusion combined with azacitidine after allogeneic HSCT in pediatric AML: a single-center retrospective analysis. [PDF]

Front Pharmacol
Bica AM, Marcu AD, Jercan CG, Iordan I, Serbanica AN, Avramescu I, Colita M, Popa DC, Constantinescu I, Ichim AM, Colita A, Colita A.   +11 more
europepmc   +1 more source

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Journal of Clinical Oncology, 2017
B. Scott, M. Pasquini, B. Logan, Juan Wu, S. Devine, D. Porter, R. Maziarz, E. Warlick, H. Fernandez, E. Alyea, M. Hamadani, A. Bashey, S. Giralt, N. Geller, E. Leifer, J. Le-Rademacher, A. Mendizabal, M. Horowitz, H. Deeg, M. Horwitz   +19 more
semanticscholar   +1 more source

Immuno-protective impact of Kangfuxin liquid on systematic toxicity associated with autologous hematopoietic stem cell transplantation in multiple myeloma. [PDF]

Front Med (Lausanne)
Wu X, Tang M, Deng T, Qu F, Jiang F, Zhou Q, Lin W, Wang X.   +7 more
europepmc   +1 more source